ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Nov 09, 2016 22:20 JST
Source:
Sino Harbour Holdings Group Limited
Sino Harbour Announces FY2017 Interim Results
Profit Attributable to Owners Up 22.7% YoY to RMB47.2 Million
HONG KONG, Nov 09, 2016 - (ACN Newswire) - Sino Harbour Holdings Group Limited ("Sino Harbour" or the "Group") (Stock code: 1663) today announced its unaudited interim results for the six months ended 30 September 2016 ("the period under review").
During the period under review, the Group's revenue increased by 32.6% to approximately RMB506.5 million, mainly attributable to the delivery of residential units of Nanchang Sino Harbour Kaixuan City Zone 3 as well as Fuzhou Hua Cui Ting Yuan Phase 3, with profit attributable to owners surging 22.7% year-on-year to RMB47.2 million. Gross profit margin improved by 6.2 percentage points to 21.2% due to a higher profit margin of Nanchang Sino Harbour Kaixuan City Zone 3.
As at 1 November 2016, the Group sold between 90% to 100% of the units in the pre-sale of three property projects, namely Nanchang Sino Harbour Kaixuan City Zone 3, Fuzhou Hua Cui Ting Yuan Phase 3 and Yichun Royal Lake City Phase 2, proof of the popularity of its property projects in the market.
As at 30 September 2016, the Group's properties held under development increased to approximately RMB1,338.4 million from approximately RMB1,312.5 million as at 31 March 2016. The increase was mainly attributable to the construction progress of Sino Harbour Kaixuan Square (formerly known as Hangzhou Ganglian Sino Africa Tower Project). It proves the Group aims at maintaining sufficient saleable resources, which is expected to support solid sales growth ahead.
In the meantime, Sino Harbour continues to diversify its business and explore development opportunities in pharmaceutical operations. Subsequent to a joint venture agreement signed in December 2015, the Group has entered into a supplemental agreement in early November, 2016, announcing its shareholding of the joint venture is to increase from the original 60% to 75%. The joint venture is to establish a service centre for pharmaceutical services (the "Pharmaceutical Centre") and enable the Pharmaceutical Centre to pass the relevant US Food and Drug Administration ("FDA") inspection and/or audit in order to qualify to issue testing and analytical reports according to the regulations promulgated and enforced by the FDA. Mr. WONG Lui, Executive Director of the Group, said, "Looking ahead, Sino Harbour will carefully assess development opportunities in the property sector and at the same time continue to explore opportunities in the pharmaceutical and healthcare arenas, so as to fully capture chances to grow its business in the future and achieve the goals of having a diversified business and multiple income sources in the long run."
About Sino Harbour Holdings Group Limited
Sino Harbour is an early-mover in developing high potential PRC property projects. Currently, the Group is also actively diversifying its business into pharmaceutical related and science and biotechnology related industries.
For media enquiries:
Strategic Financial Relations Limited
Vicky Lee / Sophie Du / Kyla Yao
Tel: +852 2864 4834 / +852 2114 4901 / +852 2114 4914
Fax: +852 2527 1196
Email:
vicky.lee@sprg.com.hk
/
sophie.du@sprg.com.hk
/
kyla.yao@sprg.com.hk
Source: Sino Harbour Holdings Group Limited
Sectors: Daily Finance, Real Estate & REIT
Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Latest Release
POSCO Future M and Honda Reach Basic Agreement on Collaboration for Production of Cathode Materials for Automotive Batteries in Canada
Apr 29, 2024 14:25 JST
Honda Plans to Establish Comprehensive Electric Vehicle Value Chain in Ontario, Canada
Apr 29, 2024 14:16 JST
JCB enables JCB Contactless acceptance at Taichung MRT in Taiwan
Apr 26, 2024 10:00 JST
Mazda Production and Sales Results for March 2024 and for April 2023 through March 2024
Apr 25, 2024 18:21 JST
MHI Begins Operation of SOEC Test Module the Next-Generation High-Efficiency Hydrogen Production Technology at Takasago Hydrogen Park
Apr 25, 2024 17:45 JST
GAC Honda to Begin Sales of All-new e:NP2, the Second Model of e:N Series
Apr 25, 2024 16:50 JST
Toyota Exhibiting at Beijing Motor Show 2024
Apr 25, 2024 16:25 JST
Honda Reaches Basic Agreement with Asahi Kasei on Collaboration for Production of Battery Separators for Automotive Batteries in Canada
Apr 25, 2024 11:10 JST
UNIQLO Sponsors KAWS + Warhol Exhibition Tour, Starting in Pittsburgh
Apr 25, 2024 09:00 JST
Mitsubishi Power Begins Commercial Operation of Seventh M701JAC Gas Turbine in Thailand GTCC Project; Achieves 75,000 AOH To-Date
Apr 24, 2024 17:19 JST
MC and Denka Sign J/V Agreement in Fullerene Business
Apr 24, 2024 17:02 JST
Mitsubishi Motors Posts Record Sales in the Philippines in FY2023
Apr 24, 2024 13:56 JST
NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance
Apr 24, 2024 13:25 JST
Fujitsu SX Survey reveals key success factors for sustainability
Apr 23, 2024 10:25 JST
Fujitsu and METRON collaborate to drive ESG success: slashing energy costs, boosting productivity with new manufacturing industry solutions
Apr 22, 2024 16:09 JST
NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II
Apr 22, 2024 15:09 JST
Soft Space Launches the First and Only JCB Payment Gateway in Malaysia
Apr 22, 2024 15:00 JST
TOYOTA GAZOO Racing takes a one-two in Croatian thriller
Apr 22, 2024 10:47 JST
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
More Latest Release >>
Related Release
Sino Harbour Announces 2016/2017 Third Quarter Results; Profit Up 152.3% YoY to RMB79.5 Million
February 13 2017 19:24 JST
Sino Harbour Establishes New Subsidiary; Proposes to Tap Stem Cell Sector in Guangxi, the PRC
January 20 2017 17:45 JST
Sino Harbour Signs Framework Agreement to Tap the Strong Potential of the Promising Stem Cells Sector
February 22 2016 17:59 JST
Sino Harbour Enters into Joint Venture Agreement; Expands into Pharmaceutical Inspection Industry
December 15 2015 18:48 JST
Sino Harbour Successfully Secures Premium Commercial Land Use Rights in Hangzhou, the PRC
April 25 2013 18:20 JST
Sino Harbour Announces FY2011/12 Annual Results
May 30 2012 12:33 JST
Sino Harbour Announces FY2011/12 Interim Results
November 15 2011 15:40 JST
More Press release >>